Mayo Clinic hematologist, Dr. Yi Lin, discusses what a patient can expect when undergoing chimeric antigen receptor T cell therapy (CAR-T cell therapy) at Mayo Clinic. Learn more about the process of:
Mayo Clinic's CAR-T Cell Therapy Program offers a new cancer immunotherapy that involves genetically modifying T cells to activate the immune system to recognize and destroy certain cancers. Learn more: https://mayocl.in/2JdrlO2.
Liked by Lisa Lucier, Connect Moderator
Send an email to invite people you know to join the Hematology page.